A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma
Clinical trial NCT02993731 · COMPLETED
Trial details
- NCT number
- NCT02993731
- Sponsor
- Sumitomo Pharma America, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2020-03-01
- Enrollment
- 1134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.